Garin A M, Lichinitser M R, Dmitrieva N V, Rubtsov B I, Leneva N V
Vopr Onkol. 1988;34(2):192-6.
57 patients with disseminated tumors of various sites received 10 daily doses of 600 mg/m2 leakadin intravenously. The immunostimulating effect was observed (OKT4/OKT8 normalization). The data on leakadin pharmacokinetics are discussed.